Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fletcher

Showing results (201-210 of 326) with videos related to

Pageof 33
Sort By:
Antiviral Therapy|July 26, 2005
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugsMarta Boffito, Edward Acosta, David Burger, et al.
Genes, Brain, and Behavior|August 3, 2020
Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L-Dopa-induced dyskinesia in parkinsonian ratsShetty Ravi Dyavar, Lisa F Potts, Goichi Beck, et al.
AIDS (London, England)|January 11, 2000
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884C V Fletcher, E P Acosta, H Cheng, et al.
AIDS (London, England)|May 26, 2011
Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescentsJennifer J Kiser, Richard M Rutstein, Pearl Samson, et al.
Frontiers in Immunology|November 1, 2021
Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV InfectionOmalla A Olwenyi, Samuel D Johnson, Kabita Pandey, et al.
Clinical Pharmacology and Therapeutics|October 29, 2010
Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivoJ Chen, R C Garner, L S Lee, et al.
The Journal of Infectious Diseases|August 6, 2004
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjectsRonald Swanstrom, Ronald J Bosch, David Katzenstein, et al.
Clinical and Translational Science|September 20, 2019
Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot StudyEric S Daar, Marc I Rosen, Yan Wang, et al.
Journal of the Pediatric Infectious Diseases Society|April 23, 2016
Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young AdultsTim R Cressey, Ram Yogev, Andrew Wiznia, et al.
AIDS (London, England)|February 20, 2022
Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppressionCourtney V Fletcher, Eugène Kroon, Timothy Schacker, et al.
Pageof 33

Showing results (201-210 of 326) with videos related to

Sort By:
Pageof 33
Antiviral Therapy|July 26, 2005
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugsMarta Boffito, Edward Acosta, David Burger, et al.
Genes, Brain, and Behavior|August 3, 2020
Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L-Dopa-induced dyskinesia in parkinsonian ratsShetty Ravi Dyavar, Lisa F Potts, Goichi Beck, et al.
AIDS (London, England)|January 11, 2000
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884C V Fletcher, E P Acosta, H Cheng, et al.
AIDS (London, England)|May 26, 2011
Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescentsJennifer J Kiser, Richard M Rutstein, Pearl Samson, et al.
Frontiers in Immunology|November 1, 2021
Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV InfectionOmalla A Olwenyi, Samuel D Johnson, Kabita Pandey, et al.
Clinical Pharmacology and Therapeutics|October 29, 2010
Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivoJ Chen, R C Garner, L S Lee, et al.
The Journal of Infectious Diseases|August 6, 2004
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjectsRonald Swanstrom, Ronald J Bosch, David Katzenstein, et al.
Clinical and Translational Science|September 20, 2019
Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot StudyEric S Daar, Marc I Rosen, Yan Wang, et al.
Journal of the Pediatric Infectious Diseases Society|April 23, 2016
Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young AdultsTim R Cressey, Ram Yogev, Andrew Wiznia, et al.
AIDS (London, England)|February 20, 2022
Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppressionCourtney V Fletcher, Eugène Kroon, Timothy Schacker, et al.
Pageof 33